About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Cleveland | 263 Studies

Clinical Trials Prostate CancerCleveland

Prostate Cancer Clinical Trials in Cleveland

Find 263 clinical trials for prostate cancer near Cleveland, Ohio. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Cleveland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 41-60 of 263 trials

RecruitingA Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate CancerThe purpose of this study is to identify the recommended phase 2 combination dose (RP2CD) of JNJ-78278343 in combination with JNJ-95298177 in Part 1 (Dose confirmation) of the…NCT07082920·Sarasota, Florida and 5 others CompletedA Pilot Study of [Ga-68]PSMA PET/MRI for the Assessment of PSMA-positive TumorsThe purpose of this study is to see if positron emission tomography/ magnetic resonance imaging (PET/MRI) can be used to monitor the effectiveness of cancer treatment using an…NCT02978586·Cleveland, Ohio RecruitingMDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)The purpose of this study is to find out if giving radiation therapy (RT) to areas of metastatic prostate cancer at the time a participant is diagnosed will help control disease…NCT06150417·New York, New York and 2 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedDigital PET/CT Using [Ga-68]PSMA vs. [F-18]NaF for Evaluation of Osseous Metastatic Involvement in Prostate Cancer PatientsThe purpose of this study is to evaluate a radioactive diagnostic study drug, which is called Gallium-68 Prostate Specific Membrane Antigen (\[Ga-68\]PSMA) for detection of bone…NCT05527483·Cleveland, Ohio

Active not recruitingARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate CancerThis is a phase 1 study to assess the safety and tolerability of ARX517 as monotherapy or combination therapy in adult subjects with metastatic prostate cancer (mPC).NCT04662580·La Jolla, California and 11 others

CompletedIntrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical ProstatectomyIntrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men with Low PSA Biochemical Recurrence of Prostate Cancer Following…NCT06604442·Phoenix, Arizona and 8 others

CompletedA Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer PatientsThe purpose of the study is to compare the response rates for prostate cancer patients taking chemotherapy plus enzastaurin versus chemotherapy plus placebo.NCT00466440·Fullerton, California and 27 others

Active not recruitingTesting the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE TrialThis phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery.NCT04134260·Phoenix, Arizona and 349 others

CompletedTestosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide ResistanceAsymptomatic men with progressive metastatic Castration-resistant prostate cancer (CRPC) post- treatment with abiraterone acetate (pre-chemotherapy for metastatic disease) will be…NCT02286921·Birmingham, Alabama and 16 others

WithdrawnSingle-Port Versus Multi-Port Robotic Radical ProstatectomyThe purpose of this study is to compare two different techniques to perform the standard of care surgery to treat prostate cancer.NCT04696263·Cleveland, Ohio

Active not recruitingSurgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate CancerRATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00430183·Anchorage, Alaska and 225 others

TerminatedRovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid TumorsThe primary objective of this study is to assess the safety and tolerability of rovalpituzumab tesirine in subjects with specific delta-like protein 3-expressing advanced solid…NCT02709889·Gilbert, Arizona and 29 others

CompletedCorrelative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate CancerThe purpose of this study is to see if eating vitamin D, omega 3 and turmeric (curcumin) slows the growth of prostate cancer in men on active surveillance.NCT03290417·Cleveland, Ohio

RecruitingEfficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic PainThe purpose of this study to perform a randomized, sham controlled analysis of the effectiveness of both fSWT and rWT in the relief of erectile dysfunction and chronic pelvic pain…NCT05868668·Cleveland, Ohio

WithdrawnFluciclovine (Axumin) PET/CT vs. NaF PET/CT in Prostate Cancer Osseous Metastatic DiseaseThe purpose of this study is to look at whether F-18 Fluciclovine (i.e. Axumin) is better or as good as F-18 Sodium Fluoride (F-18 NaF) when looking at bone disease from prostate…NCT04765423·Cleveland, Ohio

RecruitingA Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate CancerThe main purpose of the study is to assess the safety and tolerability of AZD2284, AZD2287, and AZD2275.NCT06879041·Palo Alto, California and 15 others

Active not recruitingTesting the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean StudyThis phase II trial compares the usual treatment of radiation therapy alone to using the study drug, relugolix, plus the usual radiation therapy in patients with…NCT05053152·Phoenix, Arizona and 244 others

TerminatedDefined Green Tea Catechin Extract in Treating Patients With Localized Prostate Cancer Undergoing SurgeryThis randomized pilot phase II trial studies the side effects and how well defined green tea catechin extract works in treating patients with localized prostate cancer undergoing…NCT01340599·Cleveland, Ohio

Active not recruitingAbiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With DocetaxelThis randomized phase II trial studies how well abiraterone acetate and antiandrogen therapy, with or without cabazitaxel and prednisone, work in treating patients with…NCT03419234·Fairbanks, Alaska and 671 others

CompletedEpoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate CancerRATIONALE: Epoetin alfa may stimulate red blood cell production and may help improve cancer-related anemia and fatigue.NCT00060398·Modesto, California and 139 others

PreviousPage 3 of 14Next

Other Conditions in Cleveland

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma